Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.
Brouwer, R M
Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy. [electronic resource] - Journal of cardiovascular pharmacology 1985 - S38-44 p. digital
Publication Type: Journal Article; Review
0160-2446
10.1097/00005344-198507004-00008 doi
Adrenergic beta-Antagonists--adverse effects
Calcium Channel Blockers--adverse effects
Cardiovascular Diseases--chemically induced
Diltiazem--adverse effects
Drug Therapy, Combination
Heart Conduction System--drug effects
Hemodynamics--drug effects
Humans
Hypertension--drug therapy
Nifedipine--adverse effects
Verapamil--adverse effects
Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy. [electronic resource] - Journal of cardiovascular pharmacology 1985 - S38-44 p. digital
Publication Type: Journal Article; Review
0160-2446
10.1097/00005344-198507004-00008 doi
Adrenergic beta-Antagonists--adverse effects
Calcium Channel Blockers--adverse effects
Cardiovascular Diseases--chemically induced
Diltiazem--adverse effects
Drug Therapy, Combination
Heart Conduction System--drug effects
Hemodynamics--drug effects
Humans
Hypertension--drug therapy
Nifedipine--adverse effects
Verapamil--adverse effects